AC092881.1 | HCG2014696 {ECO:0000313|EMBL:EAW97250.1}; PRO1454 {ECO:0000313|EMBL:AAG35485.1} | Predicted intracellular proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
ADAM8 | ADAM metallopeptidase domain 8 | CD markers Enzymes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| ![](/images/64637/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/64637/143728_A_5_8_rna_selected_60x60.jpg) | Tissue enhanced |
AFF2 | AF4/FMR2 family, member 2 | Disease related genes Plasma proteins Predicted intracellular proteins
| ![](/images/3139/9397_B_9_6_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/3139/9396_B_8_6_rna_selected_60x60.jpg) | Tissue enhanced |
APOBEC3A | Apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3A | Predicted intracellular proteins
| ![](/images/43237/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/43237/93176_B_9_1_rna_selected_60x60.jpg) | Tissue enhanced |
APOBEC3B | Apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3B | Predicted intracellular proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
ARG1 | Arginase 1 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | ![](/images/3595/if_selected_60x60.jpg) | ![](/images/3595/ihc_cell_selected_60x60.jpg) | ![](/images/3595/11122_B_9_1_rna_selected_60x60.jpg) | Tissue enhanced |
ARHGAP11B | Rho GTPase activating protein 11B | Predicted intracellular proteins
| ![](/images/64479/ihc_selected_60x60.jpg) | ![](/images/64479/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/64479/144857_B_8_6_rna_selected_60x60.jpg) | Tissue enhanced |
ARHGAP9 | Rho GTPase activating protein 9 | Predicted intracellular proteins
| ![](/images/51447/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/51447/121043_B_7_7_rna_selected_60x60.jpg) | Tissue enhanced |
ASTL | Astacin-like metallo-endopeptidase (M12 family) | Enzymes Predicted secreted proteins
| ![](/images/15620/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/15620/36613_B_8_2_rna_selected_60x60.jpg) | Tissue enhanced |
ATAD5 | ATPase family, AAA domain containing 5 | Predicted secreted proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
ATP8B4 | ATPase, class I, type 8B, member 4 | Enzymes Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| ![](/images/40254/ihc_selected_60x60.jpg) | ![](/images/40254/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/40254/84933_B_7_7_rna_selected_60x60.jpg) | Tissue enhanced |
BCL2A1 | BCL2-related protein A1 | Cancer-related genes Predicted intracellular proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
BIN2 | Bridging integrator 2 | Plasma proteins Predicted intracellular proteins
| | ![](/images_static/na_center.gif) | | ![](/images/38667/106333_A_3_5_rna_selected_60x60.jpg) | Tissue enhanced |
BRCA2 | Breast cancer 2, early onset | Cancer-related genes Disease related genes Predicted intracellular proteins
| ![](/images/26815/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/26815/59972_B_9_1_rna_selected_60x60.jpg) | Tissue enhanced |
C11orf21 | Chromosome 11 open reading frame 21 | Predicted intracellular proteins
| ![](/images/37607/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/37607/74271_B_8_1_rna_selected_60x60.jpg) | Tissue enhanced |
C16orf54 | Chromosome 16 open reading frame 54 | Predicted membrane proteins
| ![](/images/60546/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/60546/134951_B_2_5_rna_selected_60x60.jpg) | Tissue enhanced |
C17orf53 | Chromosome 17 open reading frame 53 | Predicted intracellular proteins
| | | ![](/images/23004/ihc_cell_selected_60x60.jpg) | ![](/images/24430/54189_B_8_5_rna_selected_60x60.jpg) | Tissue enhanced |
C19orf38 | Chromosome 19 open reading frame 38 | Predicted membrane proteins
| ![](/images/12150/ihc_selected_60x60.jpg) | ![](/images/12150/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/12150/69225_B_7_8_rna_selected_60x60.jpg) | Tissue enhanced |
C6orf25 | Chromosome 6 open reading frame 25 | Predicted membrane proteins Predicted secreted proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
CARD9 | Caspase recruitment domain family, member 9 | Disease related genes Predicted intracellular proteins
| ![](/images/59502/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/59502/133368_B_8_5_rna_selected_60x60.jpg) | Tissue enhanced |
CCL3 | Chemokine (C-C motif) ligand 3 | Cancer-related genes Predicted secreted proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
CCL4 | Chemokine (C-C motif) ligand 4 | Cancer-related genes Predicted secreted proteins
| ![](/images/7805/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/7805/22729_B_1_3_rna_selected_60x60.jpg) | Tissue enhanced |
CCL4L1 | Chemokine (C-C motif) ligand 4-like 1 | Predicted secreted proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
CCNDBP1 | Cyclin D-type binding-protein 1 | Predicted intracellular proteins
| | | ![](/images_static/rna_center.gif) | ![](/images/20664/46918_B_9_1_rna_selected_60x60.jpg) | Tissue enhanced |
CCNE1 | Cyclin E1 | Cancer-related genes Predicted intracellular proteins
| ![](/images/18169/43894_A_6_6_selected_60x60.jpg) | | ![](/images/16682/ihc_cell_selected_60x60.jpg) | ![](/images/18169/43893_A_2_4_rna_selected_60x60.jpg) | Tissue enhanced |
CCNE2 | Cyclin E2 | Cancer-related genes Predicted intracellular proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/19374/44163_A_6_7_rna_selected_60x60.jpg) | Tissue enhanced |
CCRN4L | CCR4 carbon catabolite repression 4-like (S. cerevisiae) | Enzymes Predicted intracellular proteins
| ![](/images/12287/ihc_selected_60x60.jpg) | | ![](/images/12287/35312_A_3_5_selected_60x60.jpg) | ![](/images/12287/32154_B_3_7_rna_selected_60x60.jpg) | Tissue enhanced |
CD300E | CD300e molecule | CD markers Predicted intracellular proteins Predicted membrane proteins
| ![](/images/15570/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/15570/35890_B_9_3_rna_selected_60x60.jpg) | Tissue enhanced |
CD69 | CD69 molecule | CD markers Predicted membrane proteins
| | ![](/images_static/na_center.gif) | | ![](/images/2503/6465_A_8_7_rna_selected_60x60.jpg) | Tissue enhanced |
CD83 | CD83 molecule | CD markers Predicted membrane proteins
| | ![](/images/41454/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/2509/6584_B_9_3_rna_selected_60x60.jpg) | Tissue enhanced |
CDA | Cytidine deaminase | Enzymes Plasma proteins Predicted intracellular proteins
| ![](/images/64202/ihc_selected_60x60.jpg) | ![](/images/64202/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/64202/143881_B_7_6_rna_selected_60x60.jpg) | Tissue enhanced |
CDCA4 | Cell division cycle associated 4 | Predicted intracellular proteins
| | | ![](/images_static/rna_center.gif) | ![](/images/59416/132691_B_9_1_rna_selected_60x60.jpg) | Tissue enhanced |
CDCA5 | Cell division cycle associated 5 | Predicted intracellular proteins
| ![](/images/23691/ihc_selected_60x60.jpg) | | ![](/images/23691/ihc_cell_selected_60x60.jpg) | ![](/images/23691/51600_B_7_7_rna_selected_60x60.jpg) | Tissue enhanced |
CEACAM21 | Carcinoembryonic antigen-related cell adhesion molecule 21 | Predicted membrane proteins
| ![](/images/43411/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/43411/93696_A_1_5_rna_selected_60x60.jpg) | Tissue enhanced |
CENPU | Centromere protein U | Predicted intracellular proteins
| ![](/images/22048/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/22048/55314_B_7_8_rna_selected_60x60.jpg) | Tissue enhanced |
CFP | Complement factor properdin | Disease related genes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
CHI3L1 | Chitinase 3-like 1 (cartilage glycoprotein-39) | Cancer-related genes Disease related genes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
CKAP2L | Cytoskeleton associated protein 2-like | Predicted intracellular proteins
| ![](/images/40057/ihc_selected_60x60.jpg) | | | ![](/images/39407/86909_B_8_2_rna_selected_60x60.jpg) | Tissue enhanced |
CLDN9 | Claudin 9 | Predicted membrane proteins
| ![](/images/7322/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/7322/21563_B_9_2_rna_selected_60x60.jpg) | Tissue enhanced |
CLEC12A | C-type lectin domain family 12, member A | Predicted intracellular proteins Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/48515/114819_B_8_3_rna_selected_60x60.jpg) | Tissue enhanced |
CLEC4E | C-type lectin domain family 4, member E | Predicted intracellular proteins Predicted membrane proteins
| ![](/images/4935/ihc_selected_60x60.jpg) | ![](/images/4935/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/4935/13397_B_8_2_rna_selected_60x60.jpg) | Tissue enhanced |
CLEC7A | C-type lectin domain family 7, member A | Disease related genes Predicted intracellular proteins Predicted membrane proteins
| ![](/images/43244/ihc_selected_60x60.jpg) | ![](/images/43244/488_D5_2_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/43244/95841_B_1_2_rna_selected_60x60.jpg) | Tissue enhanced |
CNTF | Ciliary neurotrophic factor | Cancer-related genes Plasma proteins Predicted intracellular proteins
| ![](/images/19654/ihc_selected_60x60.jpg) | ![](/images/19654/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/19654/46520_B_9_1_rna_selected_60x60.jpg) | Tissue enhanced |
CR1L | Complement component (3b/4b) receptor 1-like | Predicted secreted proteins
| ![](/images/49348/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/49348/115720_B_8_3_rna_selected_60x60.jpg) | Tissue enhanced |
CSF3R | Colony stimulating factor 3 receptor (granulocyte) | Cancer-related genes CD markers Disease related genes FDA approved drug targets Predicted intracellular proteins Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/17116/37868_B_8_1_rna_selected_60x60.jpg) | Tissue enhanced |
CSNK2B-LY6G5B-1181 | Chimera CSNK2B-LY6G5B splicing isoform 1181 {ECO:0000313|EMBL:CCI79697.1}; Uncharacterized protein {ECO:0000313|Ensembl:ENSP00000365040} | Predicted intracellular proteins
| ![](/images/48307/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/48307/110802_B_8_7_rna_selected_60x60.jpg) | Tissue enhanced |
CTD-3214H19.16 | | Predicted intracellular proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
CTSW | Cathepsin W | Enzymes Plasma proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | | ![](/images/16345/36106_B_6_3_rna_selected_60x60.jpg) | Tissue enhanced |
CYP4F3 | Cytochrome P450, family 4, subfamily F, polypeptide 3 | Enzymes Predicted intracellular proteins Predicted membrane proteins
| ![](/images/58960/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/58960/133524_B_8_6_rna_selected_60x60.jpg) | Tissue enhanced |
DOK3 | Docking protein 3 | Predicted intracellular proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |